Wellpoint Recovery LLC
3930 Mezzanine Drive Suite B, Lafayette, Indiana, 47905
Service Settings
- OP Outpatient
- OD Outpatient detoxification
- OMB Outpatient methadone/buprenorphine or naltrexone treatment
- ORT Regular outpatient treatment
Facility Operation
- PVTP Private for-profit organization
Treatment Approaches
- ANG Anger management
- CBT Cognitive behavioral therapy
- MOTI Motivational interviewing
- RELP Relapse prevention
- SACA Substance use counseling approach
- TELE Telemedicine/telehealth therapy
- TRC Trauma-related counseling
- TWFA 12-step facilitation
Type Of Care
- SA Substance use treatment
- DT Detoxification
- SUMH Treatment for co-occurring serious mental health illness/serious emotional disturbance and substance use disorders
Payment Accepted
- MC Medicare
- MD Medicaid
- MI Military insurance
- TRICARE
- PI Private health insurance
- SF Cash or self-payment
License/ Certification/ Accreditation
- STAG State substance abuse agency
- STMH State mental health department
- STDH State department of health
- DEA Drug Enforcement Agency (DEA)
Facility Smoking Policy
- SMPD Smoking permitted in designated area
Opioid Medications Used In Treatment
- BU Buprenorphine used in Treatment
- NU Naltrexone used in Treatment
Type Of Alcohol Use Disorder Treatment
- ACMA Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- PMAT This facility administers/prescribes medication for alcohol use disorder
Facility Vaping Policy
- VPPD Vaping permitted in designated area
Type Of Opioid Treatment
- DB Buprenorphine detoxification
- BUM Buprenorphine maintenance
- UB Prescribes buprenorphine
- UN Administers naltrexone
- RPN Relapse prevention from naltrexone
- MWS Maintenance service with medically supervised withdrawal after stabilization
External Source Of Medications Used For Alcohol
- AUINPE In-network prescribing entity
Pharmacotherapies
- DSF Disulfiram
- BWN Buprenorphine with naloxone
- BWON Buprenorphine without naloxone
- BERI Buprenorphine (extended-release)
- NXN Naltrexone (oral)
- VTRL Naltrexone (extended-release)
- MHIV Medications for HIV treatment
- MHCV Medications for Hepatitis C treatment
- CLND Clonidine
- MMD Medication for mental disorders
- MPEP Medications for pre-exposure to prophylaxis
- NRT Nicotine replacement
- NSC Non-nicotine smoking/tobacco cessation
Assessment/Pre Treatment
- CMHA Comprehensive mental health assessment
- CSAA Comprehensive substance use assessment
- ISC Interim services for clients
- OPC Outreach to persons in the community
- MHPA Complete medical history/physical exam
- STU Screening for tobacco use
- SSA Screening for substance use
- SMHD Screening for mental disorders
- PIEC Professional interventionist/educational consultant
Testing
- DAOF Drug and alcohol oral fluid testing
- DAUT Drug or alcohol urine screening
- HIVT HIV testing
- STDT STD testing
- TBS TB screening
- HBT Testing for Hepatitis B (HBV)
- HCT Testing for Hepatitis C (HCV)
Age Groups Accepted
- YAD Young adults
- ADLT Adults
Recovery Support Services
- SHG Self-help groups
- HS Housing services
- RC Recovery coach
- PEER Mentoring/peer support
- EMP Employment counseling or training
Transitional Services
- ACC Aftercare/continuing care
- NOE Naloxone and overdose education
Detoxification (medical Withdrawal) Services
- ODTX Opioid Detoxification
- MDET Medication routinely used during detoxification
Education And Counseling Services
- HAEC HIV or AIDS education
- TAEC Hepatitis education
- HEOH Health education services other than HIV/AIDS or hepatitis
- SAE Substance use disorder education
- ICO Individual
Medical Services
- HAV Hepatitis A (HAV) vaccination
- HBV Hepatitis B (HBV) vaccination
Ancillary Services
- EIH Early intervention for HIV
- MHS Mental health services
- SPS Suicide prevention services
